Videos

Join us for an insightful on-demand webinar that delves into the key findings and discussions from the ESC Congress 2025, with a special focus on atherosclerotic cardiovascular disease (ASCVD) and lipidology. Esteemed speaker Prof. Deepak Bhatt leads the session, sharing his expertise on the latest ESC guidelines for managing dyslipidemia and hypertriglyceridemia, and providing further insights into the advancements and key trial results highlighted at the congress. The webinar also features an engaging Q&A segment where Dr. Bhatt addresses audience questions.

Prof. Lale Tokgozoglu

First published: October 30, 2025  

In this video, Prof. Christopher P. Cannon presents an infographic on physician burnout in the treatment and management of ASCVD.

Prof. Christopher P. Cannon

First published: October 6, 2025  

In this video, Prof. Christopher Cannon explored the future of ASCVD and lipidology. He talks about the recent expanded indication for evlocumab and new indication for inclisiran, upcoming guidelines on LDL management, the development of oral PCSK9 inhibitors, CETP inhibitors, upcoming trials on Lp(a), and strategies for managing triglycerides.

Prof. Christopher Cannon

First published: October 6, 2025  

In this video, Prof. Deepak Bhatt discusses the future of ASCVD and Lipidology.

Prof. Deepak Bhatt

First published: September 16, 2025  

In this video, Prof. Yi-Heng Li discusses the future of ASCVD and Lipidology in 2025.

Prof. Yi-Heng Li

First published: August 26, 2025  

In this video, Prof. Christopher P. Cannon presents an infographic on treatment persistence and non-adherence in Atherosclerotic Cardiovascular Disease.

Prof. Christopher P. Cannon

First published: July 16, 2025  

In this video, Prof. Deepak L. Bhatt presents an infographic on the role of eicosanoids in atherosclerosis with a focus on IPE as therapeutic option for CVD.

Prof. Deepak L. Bhatt

First published: May 29, 2025  

Check out our latest animated video to learn more about the one-year follow-up of the SANTORINI study.

First published: March 13, 2025  

In this video, Prof. Maciej Banach discusses the 2024 recommendations on the optimal use of LLT in established ASCVD and following ACS.

First published: March 4, 2025  

In this video, Prof. Christopher Cannon and Prof. Maciej Banach discuss the current status of lipid lowering therapy with a focus on combination therapy.

First published: March 4, 2025  

In this video, Prof Stephen Nicholls discusses the future of ASCVD and Lipidology in 2025.

First published: February 24, 2025  

Welcome to our latest video! This video explores the emerging role of inclisiran, a small interfering RNA (siRNA) therapeutic that targets PCSK9, in the management of atherosclerotic cardiovascular disease. The summary delves into the mechanism of actions of inclisiran, its safety profile, results from clinical trials and the latest data presented at the ESC congress.

First published: January 13, 2025